首页|N6-腺苷酸甲基化干预细胞增殖分化在神经系统疾病中的进展

N6-腺苷酸甲基化干预细胞增殖分化在神经系统疾病中的进展

Research progress of N6-methyladenosine in neurological diseases by regulating cell proliferation and differentiation

扫码查看
N6-甲基腺苷(m6A)修饰通过转录后水平影响RNA代谢(包括稳定性、转运、剪接和翻译),控制基因表达,参与下游生物效应.近年来发现结构重塑后的mRNA在中枢发育中高度调控,包括脑组织发育障碍、神经细胞增殖分化异常与神经损伤修复等.m6A修饰及其相关因子的动态平衡与神经系统疾病的发生发展及预后密切相关,异常时导致脑血管疾病、神经退行性疾病及精神类疾病等中枢性疾病.本文介绍了m6A甲基化修饰因子以及干预细胞增殖分化的最新研究进展,并探讨了m6A介导基因表达在神经发育和神经系统疾病中的作用.
N6-methyladenosine(m6A)modification affects RNA metabolism,including the stability,transport,splicing and translation at the post-transcriptional level,which controls gene expressions and participates in downstream biological effects.In recent years,it has been found that mRNAs after structural remodeling are highly regulated in the development of the central nervous system(CNS),including the disorders related with brain tissue development,abnormal proliferation and differentiation of nerve cells,and nerve injury repair.m6A modification and the dynamic balance of its relevant factors are closely related to the occurrence,development and prognosis of nervous system diseases,which can lead to CNS diseases such as cerebrovascular diseases,neurodegenerative diseases and mental diseases.This review introduces the latest research progress of m6A methylation modifiers and their interventions in cell proliferation and differentiation,and explores the role of m6A-mediated gene expressions in neural development and neurological diseases.

N6-methyladenosinemRNAproliferation and differentiationneurological diseasestargeted therapy

候雅清、张雷雷、冯香瑞、马晶莹、马旺然、常翔、杨琳

展开 >

712000 陕西省咸阳市,陕西中医药大学第一临床医学院

陕西省西安市中医医院

N6-甲基腺苷 mRNA 增殖分化 神经系统疾病 靶向治疗

陕西省重点研发计划市级中医医院科研能力提升项目立项计划陕西中医药大学校级科研课题

S2023-YF-YBSF-0037SZY-NLTL-2022-0132020FS01

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(2)
  • 55